The food effect on the pharmacokinetics of TQB3616 capsule in Chinse healthy subjects: a randomized, open-label, single-center, two-period, two-sequence crossover phase I clinical trial
PurposeThe purpose of this study was to evaluate the food effect on the pharmacokinetics of TQB3616 capsule in Chinse healthy subjects.MethodsThe subjects were randomly allocated to two distinct sequences in a 1:1 ratio. During each treatment periods, subjects ingested a single oral dose of 180 mg T...
Saved in:
| Main Authors: | Jun Dai, Yanan Zhou, Lei Zhang, Qing Ren, Zhengzhi Liu, Yanli Wang, Yang Cheng, Qiaohuan Deng, Haimiao Yang, Hong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1586368/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study
by: Xiaoli Liu, et al.
Published: (2025-03-01) -
Prognostic role of epidermal growth factor receptors’ expression in patients with i-ii stage of non-small cell lung cancer
by: A.P. Kolesnik, et al.
Published: (2013-08-01) -
Systems‐level interactions between insulin–EGF networks amplify mitogenic signaling
by: Nikolay Borisov, et al.
Published: (2009-04-01) -
HER2 and hormone receptor conversion after neoadjuvant therapy for breast cancer
by: Jing Wang, et al.
Published: (2025-06-01) -
Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method
by: Zuo Sai-Jie, et al.
Published: (2021-09-01)